Delivery Order SPE2DR25D3020-SPE2DR26F9P1C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,635.36 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a delivery order valued at $7,755.09 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 21, 2025, with completion expected by August 22, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $3,527.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems as part of comprehensive...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,291.68 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 25, 2025, with completion anticipated by August 26, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication commonly used in military...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $6,179.27 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $7,043.40 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on November 4, 2025, with completion expected by November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Trulicity is...
- The Defense Logistics Agency awarded a delivery order valued at $1,166.88 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 8, 2025, with completion scheduled for August 11, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems supported by the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $9,297.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military healthcare systems and veteran care...
- The Defense Logistics Agency awarded a delivery order valued at $10,058.42 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price, non-set-aside contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DR25D3020Indefinite Delivery Contract
- SPE2DR25D3020-SPE2DR26F9P1CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,845.64 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on November 17, 2025, with completion by November 18, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in federal medical supply chains to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen maintains extensive federal procurement capabilities across multiple therapeutic domains and serves as a critical vendor for military healthcare programs worldwide. The company's federal contract portfolio demonstrates consistent success in competitively awarded transactions with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, and specialized medical supplies to support defense health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 11/17/25 |